Comparison between Vaidya Sane Ayurved Laboratories IPO and SP Refractories IPO.
Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while SP Refractories IPO is a SME Fixed Price proposed to list at NSE SME.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | First Overseas Capital Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Bhh Securities Pvt.Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr whereas the issue size of the SP Refractories IPO is up to ₹4.67 Cr. The final issue price of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share and of SP Refractories IPO is ₹90.00 per share.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹73.00 per share | ₹90.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 26,30,400 shares | 2,68,800 shares |
| Fresh Issue Size (Amount) | up to ₹19.20 Cr | up to ₹2.42 Cr |
| OFS Issue Size | 0 shares | 2,49,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹2.25 Cr |
| Issue Size Total | 26,30,400 shares | 5,18,400 shares |
| Issue Size Total (Amount) | up to ₹19.20 Cr | up to ₹4.67 Cr |
Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022, while SP Refractories IPO opens on Mar 09, 2022. The closing date of Vaidya Sane Ayurved Laboratories IPO and SP Refractories IPO is Feb 15, 2022, and Mar 11, 2022, respectively.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |
|---|---|---|
| Issue Open | Feb 10, 2022 | Mar 09, 2022 |
| Issue Close | Feb 15, 2022 | Mar 11, 2022 |
| Basis Of Allotment (Tentative) | Feb 18, 2022 | Mar 16, 2022 |
| Initiation of Refunds (Tentative) | Feb 21, 2022 | Mar 17, 2022 |
| Credit of Share (Tentative) | Feb 22, 2022 | Mar 21, 2022 |
| Listing date (Tentative) | Feb 23, 2022 | Mar 22, 2022 |
Vaidya Sane Ayurved Laboratories IPO P/E ratio is 28.29, as compared to SP Refractories IPO P/E ratio of 9.94.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.08% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.34% | 69.42% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 28.29 | 9.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹76.75 Cr. | ₹16.11 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.22 | ₹5.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.84 | 16.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Vaidya Sane Ayurved Laboratories IPO Retail Individual Investors (RII) are offered 13,15,200 shares while in SP Refractories IPO retail investors are offered 13,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Vaidya Sane Ayurved Laboratories IPO and 0 shares in SP Refractories IPO.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | |
| Market Maker Reservation | 1,40,800 shares | 28,800 shares |
| QIB | 0 shares | |
| NII | 13,15,200 shares | 2,59,200 shares |
| RII | 13,15,200 shares | 2,59,200 shares |
| Employee | 0 shares | |
| Total | 26,30,400 shares | 5,18,400 shares |
Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x in total, whereas SP Refractories IPO subscribed 7.24x.
| Vaidya Sane Ayurved Laboratories IPO | SP Refractories IPO | |
|---|---|---|
| NII (times) | 2.66x | 5.64x |
| RII (times) | 2.98x | 8.85x |
| Total (times) | 2.82x | 7.24x |
